5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Buy
59
EMR Quote, Financials, Valuation and Earnings
Last price:
$112.40
Seasonality move
:
0.02%
Day range:
$109.53 - $113.44
52-week range:
$90.06 - $134.85
Dividend yield:
1.87%
P/E ratio:
26.89x
P/S ratio:
3.65x
P/B ratio:
3.28x
Volume:
3.5M
Avg. volume:
3.4M
1-year change:
-0.24%
Market cap:
$63.2B
Revenue:
$17.5B
EPS (TTM):
$4.18
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Revenue Growth (YoY) | -8.64% | -22.96% | 6.74% | 9.86% | 15.35% | |
| Cost of Revenues | $9.8B | $7.2B | $7.5B | $7.7B | $8.6B | |
| Gross Profit | $7B | $5.7B | $6.3B | $7.4B | $8.9B | |
| Gross Profit Margin | 41.76% | 44.31% | 45.68% | 48.98% | 50.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $3.5B | $3.6B | $4.2B | $5.1B | |
| Other Inc / (Exp) | -$293M | -$42M | $270M | $137M | -$557M | |
| Operating Expenses | $4.2B | $3.8B | $4B | $4.7B | $6.2B | |
| Operating Income | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Net Interest Expenses | $156M | $155M | $194M | -- | $89M | |
| EBT. Incl. Unusual Items | $2.3B | $1.8B | $2.4B | $2.9B | $2B | |
| Earnings of Discontinued Ops. | -- | $911M | $1.3B | $10.9B | $350M | |
| Income Tax Expense | $345M | $346M | $549M | $642M | $415M | |
| Net Income to Company | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Minority Interest in Earnings | -$25M | -$24M | $1M | $19M | $13M | |
| Net Income to Common Excl Extra Items | $2B | $2.3B | $3.2B | $13.2B | $2B | |
| Basic EPS (Cont. Ops) | $3.26 | $3.85 | $5.44 | $23.00 | $3.44 | |
| Diluted EPS (Cont. Ops) | $3.24 | $3.82 | $5.41 | $22.88 | $3.43 | |
| Weighted Average Basic Share | $602.9M | $598.1M | $592.9M | $574.2M | $571.3M | |
| Weighted Average Diluted Share | $606.6M | $601.8M | $596.3M | $577.3M | $574M | |
| EBITDA | $3.4B | $2.7B | $3.5B | $4.2B | $4B | |
| EBIT | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Revenue (Reported) | $16.8B | $12.9B | $13.8B | $15.2B | $17.5B | |
| Operating Income (Reported) | $2.8B | $2B | $2.4B | $2.8B | $2.7B | |
| Operating Income (Adjusted) | $2.5B | $1.9B | $2.7B | $3.2B | $2.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $3.3B | $3.8B | $4.4B | $4.4B | |
| Revenue Growth (YoY) | 6.46% | -25.73% | 14.13% | 16.51% | 1.28% | |
| Cost of Revenues | $2.6B | $1.8B | $2B | $2.1B | $2.1B | |
| Gross Profit | $1.9B | $1.5B | $1.8B | $2.3B | $2.4B | |
| Gross Profit Margin | 42.02% | 44.85% | 47.95% | 52.19% | 53.5% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $888M | $1B | $1.3B | $1.3B | |
| Other Inc / (Exp) | $41M | $29M | $10M | $22M | -$189M | |
| Operating Expenses | $1.1B | $945M | $1.1B | $1.6B | $1.5B | |
| Operating Income | $734M | $531M | $682M | $715M | $859M | |
| Net Interest Expenses | $38M | $51M | $53M | $26M | $41M | |
| EBT. Incl. Unusual Items | $737M | $509M | $639M | $711M | $629M | |
| Earnings of Discontinued Ops. | -- | $246M | $265M | -$46M | -- | |
| Income Tax Expense | $169M | $80M | $134M | $162M | $199M | |
| Net Income to Company | $568M | $429M | $505M | $549M | $429M | |
| Minority Interest in Earnings | -$7M | -$1M | $22M | -$2M | $55M | |
| Net Income to Common Excl Extra Items | $561M | $674M | $792M | $501M | $485M | |
| Basic EPS (Cont. Ops) | $0.94 | $1.13 | $1.39 | $0.88 | $0.86 | |
| Diluted EPS (Cont. Ops) | $0.93 | $1.13 | $1.38 | $0.87 | $0.86 | |
| Weighted Average Basic Share | $599.4M | $593.3M | $570.9M | $571.4M | $563M | |
| Weighted Average Diluted Share | $602.8M | $596.5M | $573.6M | $574.1M | $565.4M | |
| EBITDA | $1B | $735M | $973M | $1.2B | $1.1B | |
| EBIT | $775M | $564M | $710M | $801M | $715M | |
| Revenue (Reported) | $4.4B | $3.3B | $3.8B | $4.4B | $4.4B | |
| Operating Income (Reported) | $734M | $531M | $682M | $715M | $859M | |
| Operating Income (Adjusted) | $775M | $564M | $710M | $801M | $715M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.1B | $10.8B | $14.5B | $16.5B | $17.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10B | $5.8B | $7.7B | $8.3B | $8.3B | |
| Gross Profit | $7.1B | $5B | $6.8B | $8.2B | $9.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.9B | $3.2B | $3.9B | $4.7B | $5.1B | |
| Other Inc / (Exp) | -$168M | $436M | -$223M | -$26M | -$590M | |
| Operating Expenses | $4.2B | $3.4B | $4.4B | $5.5B | $6.1B | |
| Operating Income | $2.9B | $1.6B | $2.5B | $2.7B | $3.2B | |
| Net Interest Expenses | $163M | $167M | $205M | -- | $99M | |
| EBT. Incl. Unusual Items | $2.5B | $1.9B | $2B | $2.7B | $2.5B | |
| Earnings of Discontinued Ops. | -- | $395M | $3.2B | $8.6B | $423M | |
| Income Tax Expense | $366M | $342M | $505M | $588M | $618M | |
| Net Income to Company | $2.2B | $1.6B | $1.5B | $2.1B | $1.9B | |
| Minority Interest in Earnings | -$29M | -$10M | $28M | -- | $52M | |
| Net Income to Common Excl Extra Items | $2.1B | $2.9B | $4.8B | $10.7B | $2.4B | |
| Basic EPS (Cont. Ops) | $3.56 | $4.81 | $8.18 | $18.79 | $4.22 | |
| Diluted EPS (Cont. Ops) | $3.54 | $4.78 | $8.13 | $18.69 | $4.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.6B | $2.7B | $3.3B | $4.4B | $4.5B | |
| EBIT | $2.7B | $2.1B | $2.3B | $3.1B | $2.9B | |
| Revenue (Reported) | $17.1B | $10.8B | $14.5B | $16.5B | $17.6B | |
| Operating Income (Reported) | $2.9B | $1.6B | $2.5B | $2.7B | $3.2B | |
| Operating Income (Adjusted) | $2.7B | $2.1B | $2.3B | $3.1B | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.6B | $6.4B | $7.1B | $8.5B | $8.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5B | $3.6B | $3.7B | $4.3B | $4B | |
| Gross Profit | $3.6B | $2.9B | $3.4B | $4.2B | $4.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $1.7B | $2B | $2.6B | $2.5B | |
| Other Inc / (Exp) | -$3M | $475M | $8M | -$155M | -$188M | |
| Operating Expenses | $2.2B | $1.8B | $2.3B | $3.1B | $3B | |
| Operating Income | $1.4B | $1.1B | $1.2B | $1.1B | $1.6B | |
| Net Interest Expenses | $78M | $90M | $101M | $39M | $49M | |
| EBT. Incl. Unusual Items | $1.3B | $1.5B | $1.1B | $886M | $1.4B | |
| Earnings of Discontinued Ops. | -- | $395M | $2.3B | -$73M | -- | |
| Income Tax Expense | $280M | $276M | $232M | $178M | $381M | |
| Net Income to Company | $1B | $1.2B | $829M | $708M | $1B | |
| Minority Interest in Earnings | -$14M | -- | $27M | $8M | $47M | |
| Net Income to Common Excl Extra Items | $1B | $1.6B | $3.1B | $643M | $1.1B | |
| Basic EPS (Cont. Ops) | $1.68 | $2.64 | $5.38 | $1.13 | $1.89 | |
| Diluted EPS (Cont. Ops) | $1.67 | $2.63 | $5.35 | $1.12 | $1.88 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | |
| EBITDA | $1.9B | $1.9B | $1.7B | $1.9B | $2.3B | |
| EBIT | $1.4B | $1.5B | $1.2B | $1.1B | $1.5B | |
| Revenue (Reported) | $8.6B | $6.4B | $7.1B | $8.5B | $8.6B | |
| Operating Income (Reported) | $1.4B | $1.1B | $1.2B | $1.1B | $1.6B | |
| Operating Income (Adjusted) | $1.4B | $1.5B | $1.2B | $1.1B | $1.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.8B | $3B | $2.3B | $2.5B | $2.9B | |
| Inventory | $1.9B | $2.1B | $1.7B | $2B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $761M | $1.1B | $1.3B | $1.2B | $1.5B | |
| Total Current Assets | $8.8B | $8.4B | $8.5B | $13.8B | $10.2B | |
| Property Plant And Equipment | $3.7B | $3.7B | $2.2B | $2.4B | $2.8B | |
| Long-Term Investments | -- | -- | -- | $3.3B | -- | |
| Goodwill | $6.7B | $7.7B | $13.9B | $14.5B | $18.1B | |
| Other Intangibles | $2.5B | $2.9B | $6.6B | $6.3B | $10.4B | |
| Other Long-Term Assets | $1.2B | $1.9B | $4.4B | $2.6B | $2.7B | |
| Total Assets | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Accounts Payable | $1.7B | $2.1B | $1.3B | $1.3B | $1.3B | |
| Accrued Expenses | $2.9B | $3.3B | $3B | $3.2B | $3.9B | |
| Current Portion Of Long-Term Debt | $322M | $538M | $516M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $1.3B | -- | -- | |
| Total Current Liabilities | $5.8B | $6.2B | $7.8B | $5B | $5.7B | |
| Long-Term Debt | $6.3B | $5.8B | $8.3B | $7.6B | $7.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.4B | $14.8B | $19.4B | $16.1B | $16.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.5B | -$1.3B | -$868M | |
| Common Equity | $8.4B | $9.9B | $10.4B | $20.7B | $21.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $42M | $40M | $6B | $5.9B | $5.9B | |
| Total Equity | $8.4B | $9.9B | $16.3B | $26.6B | $27.5B | |
| Total Liabilities and Equity | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Cash and Short Terms | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Total Debt | $7.5B | $6.7B | $10.4B | $8.2B | $7.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.3B | $6.9B | $2B | $2.3B | $1.9B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.8B | $3B | $2.3B | $2.9B | $2.9B | |
| Inventory | $2B | $2.4B | $2B | $2.4B | $2.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $849M | $1.3B | $1.2B | $1.5B | $1.6B | |
| Total Current Assets | $8B | $13.5B | $9B | $9B | $8.6B | |
| Property Plant And Equipment | $4.2B | $4.1B | $2.7B | $3.4B | $2.8B | |
| Long-Term Investments | -- | -- | -- | $3.2B | -- | |
| Goodwill | $7.8B | $7.6B | $14.1B | $18B | $18B | |
| Other Intangibles | $3.1B | $2.7B | $6.3B | $11B | $9.8B | |
| Other Long-Term Assets | $192M | $271M | $2.5B | $233M | $2.8B | |
| Total Assets | $23.8B | $29.5B | $36.1B | $46.4B | $42B | |
| Accounts Payable | $1.8B | $2B | $1.2B | $1.3B | $1.3B | |
| Accrued Expenses | $1.5B | $1.6B | $1.2B | $1.2B | $1.3B | |
| Current Portion Of Long-Term Debt | $1.5B | $2.8B | $2B | $3.2B | $6B | |
| Current Portion Of Capital Lease Obligations | $150M | $151M | $132M | $155M | $149M | |
| Other Current Liabilities | -- | -- | $1.1B | -- | $149M | |
| Total Current Liabilities | $6.3B | $8.1B | $7.5B | $7.7B | $10.8B | |
| Long-Term Debt | $5.8B | $8.2B | $8.2B | $7.6B | $8.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.6B | $18.9B | $18.8B | $19.7B | $22.7B | |
| Common Stock | $477M | $477M | $477M | $477M | $477M | |
| Other Common Equity Adj | -- | -- | -$1.1B | -$1.1B | -$1.2B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $50M | $39M | $6B | $5.9B | $17M | |
| Total Equity | $9.2B | $10.6B | $17.3B | $26.8B | $19.3B | |
| Total Liabilities and Equity | $23.8B | $29.5B | $36.1B | $46.4B | $42B | |
| Cash and Short Terms | $2.3B | $6.9B | $2B | $2.3B | $1.9B | |
| Total Debt | $7.3B | $11B | $10.1B | $10.8B | $14.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $1.4B | $1.9B | $2.3B | $1.6B | |
| Depreciation & Amoritzation | $854M | $762M | $842M | $1.1B | $1.7B | |
| Stock-Based Compensation | $110M | $197M | $125M | $250M | $260M | |
| Change in Accounts Receivable | $207M | -$18M | -$143M | -$191M | -$99M | |
| Change in Inventories | -$6M | -$11M | -$334M | -$160M | $122M | |
| Cash From Operations | $3.1B | $3.6B | $2.9B | $637M | $3.3B | |
| Capital Expenditures | $538M | $404M | $299M | $363M | $419M | |
| Cash Acquisitions | -$126M | -$1.6B | -$5.7B | -$705M | -$8.3B | |
| Cash From Investing | -$740M | -$2.1B | -$5.3B | $12.4B | -$5.4B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.3B | $71M | $5.4B | $395M | $322M | |
| Long-Term Debt Repaid | -$1.6B | -$883M | -$1.7B | -$3.6B | -$889M | |
| Repurchase of Common Stock | -$942M | -$500M | -$500M | -$2.2B | -$643M | |
| Other Financing Activities | $2M | $100M | $80M | -$169M | -$44M | |
| Cash From Financing | -$509M | -$2.4B | $2B | -$6.8B | -$2.5B | |
| Beginning Cash (CF) | $1.5B | $3.3B | $2.4B | $1.8B | $8.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.8B | -$967M | -$364M | $6.2B | -$4.5B | |
| Ending Cash (CF) | $3.3B | $2.4B | $1.8B | $8.1B | $3.6B | |
| Levered Free Cash Flow | $2.5B | $3.2B | $2.6B | $274M | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $568M | $429M | $505M | $549M | $429M | |
| Depreciation & Amoritzation | $239M | $171M | $263M | $424M | $384M | |
| Stock-Based Compensation | $61M | $43M | $40M | $73M | $59M | |
| Change in Accounts Receivable | -$157M | -$127M | -$141M | -$129M | -$181M | |
| Change in Inventories | -$24M | -$85M | -$26M | $51M | $19M | |
| Cash From Operations | $807M | $442M | $68M | $743M | $241M | |
| Capital Expenditures | $100M | $67M | $62M | $82M | $87M | |
| Cash Acquisitions | -- | $4M | -- | $76M | $1M | |
| Cash From Investing | -$52M | -$126M | -$152M | -$37M | -$122M | |
| Dividends Paid (Ex Special Dividend) | -$303M | -$306M | -$297M | -$300M | -$297M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $60M | $1.9B | $395M | $2.6B | $6.7B | |
| Long-Term Debt Repaid | -- | -$3M | -$764M | -- | $2M | |
| Repurchase of Common Stock | -$65M | -$32M | -- | -$57M | -$223M | |
| Other Financing Activities | $41M | -$7M | -$14M | -$1M | -$7.2B | |
| Cash From Financing | -$607M | $1.9B | -$141M | -$442M | -$1.1B | |
| Beginning Cash (CF) | $2.2B | $4.7B | $2.3B | $2.1B | $2.8B | |
| Foreign Exchange Rate Adjustment | -$3M | -$11M | -- | -$22M | $25M | |
| Additions / Reductions | $148M | $2.2B | -$225M | $264M | -$972M | |
| Ending Cash (CF) | $2.3B | $6.9B | $2B | $2.3B | $1.9B | |
| Levered Free Cash Flow | $707M | $375M | $6M | $661M | $154M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $1.6B | $1.5B | $2.1B | $1.9B | |
| Depreciation & Amoritzation | $915M | $628M | $1B | $1.4B | $1.6B | |
| Stock-Based Compensation | $217M | $149M | $190M | $255M | $240M | |
| Change in Accounts Receivable | -$1M | -$48M | -$251M | -$163M | -$89M | |
| Change in Inventories | $149M | -$212M | -$291M | $13M | $101M | |
| Cash From Operations | $3.7B | $2.9B | $2.4B | $1.3B | $3.2B | |
| Capital Expenditures | $535M | $322M | $280M | $401M | $430M | |
| Cash Acquisitions | -$1.6B | $452M | -$6.1B | -$9B | -$115M | |
| Cash From Investing | -$2.1B | -$189M | -$2.8B | $1.2B | $2.9B | |
| Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.2B | -$1.2B | -$1.2B | -$1.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $827M | $4.9B | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.4B | -$1.1B | -$2B | -- | -$889M | |
| Repurchase of Common Stock | -$78M | -$707M | -$2.2B | -$518M | -$1.5B | |
| Other Financing Activities | $46M | $32M | $10M | -$160M | -$7.3B | |
| Cash From Financing | -$1.8B | $1.9B | -$4.5B | -$2.2B | -$6.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$307M | $4.7B | -$4.8B | $327M | -$393M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.2B | $2.6B | $2.2B | $908M | $2.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1B | $1.2B | $829M | $708M | $1B | |
| Depreciation & Amoritzation | $483M | $349M | $523M | $846M | $767M | |
| Stock-Based Compensation | $125M | $77M | $142M | $147M | $127M | |
| Change in Accounts Receivable | $75M | $45M | -$63M | -$35M | -$25M | |
| Change in Inventories | -$61M | -$262M | -$219M | -$46M | -$67M | |
| Cash From Operations | $1.6B | $965M | $486M | $1.2B | $1B | |
| Capital Expenditures | $222M | $140M | $121M | $159M | $170M | |
| Cash Acquisitions | -$1.6B | $403M | $15M | -$8.3B | -$36M | |
| Cash From Investing | -$1.8B | $159M | $2.7B | -$8.5B | -$264M | |
| Dividends Paid (Ex Special Dividend) | -$606M | -$613M | -$603M | -$600M | -$598M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $60M | $4.9B | $395M | $2.6B | $6.7B | |
| Long-Term Debt Repaid | -$301M | -$504M | -$773M | -- | -- | |
| Repurchase of Common Stock | -$78M | -$285M | -$2B | -$304M | -$1.1B | |
| Other Financing Activities | $83M | $15M | -$55M | -$46M | -$7.3B | |
| Cash From Financing | -$842M | $3.5B | -$3B | $1.6B | -$2.4B | |
| Beginning Cash (CF) | $5.5B | $7.1B | $4.1B | $10.1B | $6.4B | |
| Foreign Exchange Rate Adjustment | $26M | -$48M | $58M | -$15M | -$73M | |
| Additions / Reductions | -$999M | $4.6B | $184M | -$5.7B | -$1.6B | |
| Ending Cash (CF) | $4.5B | $11.7B | $4.3B | $4.4B | $4.7B | |
| Levered Free Cash Flow | $1.4B | $825M | $365M | $999M | $848M | |
Get EMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMR
Sector
P/E ratio
26.89x
17.14x
PEG ratio
0.04x
0.27x
P/B ratio
3.28x
1.66x
Price / LTM sales
3.65x
0.88x
Growth Metrics
EMR
Sector
Revenue growth
1.28%
2.37%
Earnings growth
-1.15%
4.52%
Revenue (5-year growth)
-0.98%
4.4%
Earnings forecast
$1.41
$0.29
Profitability
EMR
Sector
Profitability FY 2024
$8.9B
$406.4M
Return on invested capital
6.77%
5.65%
Return on assets
5.42%
3.52%
Return on equity
9.46%
8.69%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
EMR
Sector
Total cash
$1.9B
$163.2M
Short term investments
--
$37.1M
Total assets
$44.2B
$1.8B
Long term debt
$14.2B
$282.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 41.65% over the past day.
Buy
62
RGC alert for May 9
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
85
TPB alert for May 9
Turning Point Brands [TPB] is down 6.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
